Reported 8 months ago
The most significant research calls from Wall Street's top analysts include B. Riley upgrading Skyworks to Buy with a $130 price target, TransUnion being upgraded by BofA to Buy, iRhythm being upgraded by Wolfe Research to Outperform, and more. On the other hand, Spirit AeroSystems was downgraded by Benchmark, Zentalis by UBS, Esperion by BofA, and Prelude Therapeutics by Barclays. Additionally, new coverage initiations include Oppenheimer on ESAB, TD Cowen on Vericel, BofA on Samsara, JMP Securities on Life360, and BofA reinstating coverage on Cardlytics.
Source: YAHOO